Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rene Christopher Goehrum Insider Profile
4 Followers
Rene Christopher Goehrum, Chairman, President & Chief Executive Officer at Biosyent, holds 335.87K shares in Biosyent (Ticker: TSE:RX). Most recently, Rene Christopher Goehrum Sold C$1,522 shares of Biosyent on Jun 18, 2024 for an estimated value of 14.28K.
Rene Christopher Goehrum Biosyent (RX)Chairman, President & Chief Executive Officer
Biosyent (RX)
Chairman, President & Chief Executive Officer
Ranked #18,316 out of 99,218 Corporate Insiders
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+14.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Rene Christopher Goehrum's holdings
Insider Roles
Chairman, President & Chief Executive Officer
Roles that Rene Christopher Goehrum holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rene Christopher Goehrum
Rene Christopher Goehrum's Trading History
List of latest transactions for each holding click on a transaction to see Rene Christopher Goehrum's performance on stock
You May Also Like
Rene Christopher Goehrum insider profile FAQ
What is the percentage of profitable transactions made by Rene Christopher Goehrum?
The percentage of profitable transactions made by Rene Christopher Goehrum is 50%.
What is the average return per transaction made by Rene Christopher Goehrum?
The average return per transaction made by Rene Christopher Goehrum is 14.40%.
What stocks does Rene Christopher Goehrum hold?
Rene Christopher Goehrum holds: TSE:RX stocks.
What was Rene Christopher Goehrum’s latest transaction?
Rene Christopher Goehrum latest transaction was an Informative Sell of C$14.28K.
What was Rene Christopher Goehrum's most profitable transaction?
Rene Christopher Goehrum’s most profitable transaction was an Informative Buy of TSE:RX stock on April 1, 2020. The return on the trade was 105.50%.
What is Rene Christopher Goehrum's role in Biosyent?
Rene Christopher Goehrum's role in Biosyent is Chairman, President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.